11-beta hydroxysteroid dehydrogenase inhibitors (Ipsen)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name11-beta hydroxysteroid dehydrogenase inhibitors (Ipsen)
Drug Alias Name11-beta HSD inhibitors (Ipsen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action11-beta-hydroxysteroid dehydrogenase inhibitors
Targets11-beta-hydroxysteroid dehydrogenase
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIpsen SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIpsen SA
Active IndicationsN/A
Inactive IndicationsMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A